Galcanezumab treatment changes visual related EEG connectivity patterns in migraine patients
Cephalalgia · 2023
DOI: 10.1177/03331024231189751 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Cephalalgia, 2023. Verfasst von Marianna La Rocca und 8 weiteren Autor:innen. Beteiligte Einrichtung: Physics Department, Bari Aldo Moro University, Bari, Italy. Hauptthemen laut MEDLINE: Migraine Disorders. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministery for University Italy.
Abstract (Originalsprache)
Background
Monoclonal antibodies against calcitonin gene-related peptides (CGRP) are innovative therapies for migraine treatment. Although they are clinically effective, how anti-CGRP treatment reduces migraine attacks still remains unclear.
Objective
In this observational case–control study, we aimed to apply graph theory to EEG data from 20 migraine patients and 10 controls to investigate the effects of 3 months of galcanezumab on brain connectivity.
Methods
We analyzed EEG rhythms during black-white pattern reversal stimulation with 0.5 cycle per degree spatial frequency before (T0) galcanezumab injection, as well as after 3 months (T2). EEG recordings made 1 hour after galcanezumab administration served as the control session (T1). Patients’ connectivity patterns obtained at T0, T1 and T2 were compared with normal controls.
Results
We found that galcanezumab increased network integration (with a 5% significance level corrected with the false discovery rate), changing the intensity of connections between the occipital through the frontal areas. At 3 months follow up, patients with persistent high headache intensity had a minor effect on the strength of connections (evaluated using Kendall’s rank correlation test and p < 0.05).
Conclusions
The potent anti-nociceptive action that galcanezumab exerts at a peripheral level could restore cortical connections and possibly factors predisposing to attack onset.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Physics Department, Bari Aldo Moro University, Bari, Italy.
- Laboratory of Neuro Imaging, USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA.
- INFN, Bari Section, Bari, Italy.
- DiBraiN Department, Neurophysiopathology Unit, Bari Aldo Moro University, Bari, Italy.
ORCID-Profile: Marina de Tommaso
Förderung
- Ministery for University Italy
Zitieren
APA
La Rocca, M., Laporta, A., Clemente, L., Ammendola, E., Delussi, M. D., Ricci, K., Tancredi, G., Stramaglia, S., & de Tommaso, M. (2023). Galcanezumab treatment changes visual related EEG connectivity patterns in migraine patients. Cephalalgia. https://doi.org/10.1177/03331024231189751
Vancouver
La Rocca M, Laporta A, Clemente L, Ammendola E, Delussi MD, Ricci K, et al. Galcanezumab treatment changes visual related EEG connectivity patterns in migraine patients. Cephalalgia. 2023. doi:10.1177/03331024231189751
BibTeX
@article{LaRocca2023,
author = {La Rocca, Marianna and Laporta, Anna and Clemente, Livio and Ammendola, Elena and Delussi, Marianna Diletta and Ricci, Katia and Tancredi, Giusy and Stramaglia, Sebastiano and de Tommaso, Marina},
title = {Galcanezumab treatment changes visual related EEG connectivity patterns in migraine patients},
journal = {Cephalalgia},
year = {2023},
doi = {10.1177/03331024231189751}
}
EUVIMED